Cureatr, Inc., a comprehensive medication management (CMM) technology and services company, has announced the creation of its Strategic Advisory Board (SAB) to provide external expertise, insight, and guidance to the company´s management in regards to its business development, clinical strategy and direction, research and development activities and solution portfolio, the company said.
The four inaugural members of Cureatr´s SAB bring over a century of collective experience and expertise in several healthcare sectors including, health care information technology, managed care, informatics and outcomes measurement, quality improvement, CMS/HHS, employer health benefits, healthcare legislation and policy, retail pharmacy operations, reimbursement and M&A.
Cureatr´s Strategic Advisory Board members are:
Greg Downing, DO, PharmD, PhD, Founder of Innovation Horizons, LLC
Jim Jorgenson, CEO and Board Chair, Visante, Inc. and Visante Limited
Terry McInnis, MD, MPH, CPE, President, Blue Thorn, Inc.
Ben Rooks, Founder & Managing Principal, ST Advisors, Inc.
Cureatr is a comprehensive medication management (CMM) solutions company dedicated to repairing the United States´ USD 528 Billion suboptimal medication management problem. Visit www.cureatr.com to learn more.